| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRE OR5D16 ESR1 PECAM1 INSRR NTSR2 OR13G1 PTAFR GFRA2 OR4M2B NPFFR2 MET OR5J2 PTPRZ1 AGTR2 TAAR9 ADGRF5 FGFR4 TAS2R30 ADGRL2 TAS2R50 ADGRA3 NPC1 PLXNA3 CYSLTR2 MCHR1 GPR37 FPR1 ROR1 OR4M1 GRIA4 CASR TAAR5 GRIK2 GRIK3 GRM2 GRM3 OR10Z1 OR4M2 IGF2R GPR176 GPR45 | 1.24e-08 | 1353 | 240 | 42 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5D16 ESR1 NTSR2 OR13G1 PTAFR OR4M2B NPFFR2 OR5J2 AGTR2 TAAR9 ADGRF5 TAS2R30 ADGRL2 TAS2R50 ADGRA3 CYSLTR2 MCHR1 GPR37 FPR1 OR4M1 CASR TAAR5 GRIK3 GRM2 GRM3 OR10Z1 OR4M2 GPR176 GPR45 | 9.64e-07 | 884 | 240 | 29 | GO:0004930 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.56e-05 | 27 | 240 | 5 | GO:0008066 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 9.18e-05 | 8 | 240 | 3 | GO:0004571 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.37e-04 | 9 | 240 | 3 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.37e-04 | 9 | 240 | 3 | GO:0001640 | |
| GeneOntologyMolecularFunction | rRNA (cytosine-N4-)-methyltransferase activity | 1.44e-04 | 2 | 240 | 2 | GO:0071424 | |
| GeneOntologyMolecularFunction | group II metabotropic glutamate receptor activity | 1.44e-04 | 2 | 240 | 2 | GO:0001641 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 1.60e-04 | 43 | 240 | 5 | GO:0043548 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 1.93e-04 | 10 | 240 | 3 | GO:0015924 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 2.47e-04 | 103 | 240 | 7 | GO:0004553 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 7.01e-04 | 15 | 240 | 3 | GO:0004559 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 7.10e-07 | 86 | 240 | 9 | GO:0007193 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5D16 PDE2A ESR1 NTSR2 OR13G1 PTAFR ADCY5 OR4M2B JAK2 NPFFR2 MET OR5J2 AGTR2 C3 TAAR9 ADGRF5 GNAT1 TAS2R30 ADGRL2 TAS2R50 ADGRA3 CYSLTR2 MCHR1 GPR37 FPR1 GRK6 OR4M1 CASR TAAR5 GRIK3 GRM2 GRM3 OR10Z1 OR4M2 PPP3CA IGF2R GPR176 GPR45 | 8.12e-07 | 1395 | 240 | 38 | GO:0007186 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | PDE2A ADCY5 ADGRF5 GNAT1 ADGRL2 MCHR1 GPR37 FPR1 OR4M1 CASR GRIK3 GRM2 GRM3 OR4M2 GPR176 | 1.42e-06 | 286 | 240 | 15 | GO:0007188 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PECAM1 FAT2 CNTN5 PCDH10 FAT4 PCDHGA6 PCDHGA5 PCDHGA2 PCDHA13 PCDHA4 TENM3 | 1.27e-05 | 187 | 240 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | acyl-CoA biosynthetic process | 2.15e-05 | 49 | 240 | 6 | GO:0071616 | |
| GeneOntologyBiologicalProcess | thioester biosynthetic process | 2.15e-05 | 49 | 240 | 6 | GO:0035384 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 3.48e-05 | 172 | 240 | 10 | GO:0043604 | |
| GeneOntologyBiologicalProcess | response to dexamethasone | 4.20e-05 | 55 | 240 | 6 | GO:0071548 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 4.66e-05 | 178 | 240 | 10 | GO:0044272 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate biosynthetic process | 7.58e-05 | 61 | 240 | 6 | GO:0033866 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate biosynthetic process | 7.58e-05 | 61 | 240 | 6 | GO:0034030 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate biosynthetic process | 7.58e-05 | 61 | 240 | 6 | GO:0034033 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent glycoprotein ERAD pathway | 8.34e-05 | 8 | 240 | 3 | GO:0097466 | |
| GeneOntologyBiologicalProcess | protein deglycosylation involved in glycoprotein catabolic process | 8.34e-05 | 8 | 240 | 3 | GO:0035977 | |
| GeneOntologyBiologicalProcess | protein alpha-1,2-demannosylation | 8.34e-05 | 8 | 240 | 3 | GO:0036508 | |
| GeneOntologyBiologicalProcess | protein demannosylation | 8.34e-05 | 8 | 240 | 3 | GO:0036507 | |
| GeneOntologyBiologicalProcess | mannose trimming involved in glycoprotein ERAD pathway | 8.34e-05 | 8 | 240 | 3 | GO:1904382 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 1.24e-04 | 9 | 240 | 3 | GO:0007196 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 1.24e-04 | 9 | 240 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | positive regulation of protein oxidation | 1.35e-04 | 2 | 240 | 2 | GO:1904808 | |
| GeneOntologyBiologicalProcess | regulation of protein oxidation | 1.35e-04 | 2 | 240 | 2 | GO:1904806 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | PDE2A ACACB PDK4 RAB1C EXTL1 DCK YJEFN3 ADCY5 XYLT2 TM9SF2 PEMT VNN1 HSPA8 SLC27A2 ALPG NPC1 LARGE2 NAGK MAN1C1 GALNT12 PPCS GUSB OGDHL EDEM1 DSEL HACD1 MMUT GALNT4 MAN1B1 | 2.25e-04 | 1226 | 240 | 29 | GO:1901135 |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 2.63e-04 | 142 | 240 | 8 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 2.63e-04 | 142 | 240 | 8 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 2.63e-04 | 142 | 240 | 8 | GO:0034032 | |
| GeneOntologyBiologicalProcess | response to glycoprotein | 3.17e-04 | 12 | 240 | 3 | GO:1904587 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 3.02e-05 | 6 | 243 | 3 | GO:0032983 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRE PDE2A CSMD2 MET STXBP1 PTPRZ1 CNTN5 DMD ADGRL2 PCDH10 HSPA8 GRIA4 GRIK2 GRIK3 GRM2 GRM3 SLC6A7 TENM3 SEPTIN7 | 5.59e-05 | 583 | 243 | 19 | GO:0097060 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 1.24e-04 | 9 | 243 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | neuron projection terminus | 4.18e-04 | 233 | 243 | 10 | GO:0044306 | |
| GeneOntologyCellularComponent | presynaptic membrane | PDE2A STXBP1 CNTN5 GRIA4 GRIK2 GRIK3 GRM2 GRM3 SLC6A7 TENM3 SEPTIN7 | 4.20e-04 | 277 | 243 | 11 | GO:0042734 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 5.14e-04 | 14 | 243 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | axon | PDE2A ESR1 INSRR LMTK3 STXBP1 SACS PTPRZ1 CNTN5 DMD USH2A HSPA8 ROR1 GRIA4 CASR GRIK2 GRIK3 GRM2 GRM3 TENM3 ATP1A1 SEPTIN7 LGI1 | 7.54e-04 | 891 | 243 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | axon terminus | 8.15e-04 | 210 | 243 | 9 | GO:0043679 | |
| GeneOntologyCellularComponent | terminal bouton | 8.99e-04 | 96 | 243 | 6 | GO:0043195 | |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRE CSMD2 MET PTPRZ1 DMD ADGRL2 PCDH10 HSPA8 GRIA4 GRIK2 GRIK3 GRM2 GRM3 | 9.66e-04 | 405 | 243 | 13 | GO:0045211 |
| Domain | CarboxyPept-like_regulatory | 1.62e-06 | 17 | 234 | 5 | IPR008969 | |
| Domain | ANF_lig-bd_rcpt | 6.09e-06 | 37 | 234 | 6 | IPR001828 | |
| Domain | ANF_receptor | 6.09e-06 | 37 | 234 | 6 | PF01094 | |
| Domain | DUF2012 | 7.70e-06 | 4 | 234 | 3 | PF09430 | |
| Domain | DUF2012 | 7.70e-06 | 4 | 234 | 3 | IPR019008 | |
| Domain | Peripla_BP_I | 8.37e-06 | 39 | 234 | 6 | IPR028082 | |
| Domain | CarboxyPept_regulatory_dom | 1.57e-05 | 13 | 234 | 4 | IPR014766 | |
| Domain | - | 1.57e-05 | 13 | 234 | 4 | 2.60.40.1120 | |
| Domain | Glyco_hydro_47 | 6.55e-05 | 7 | 234 | 3 | PF01532 | |
| Domain | - | 6.55e-05 | 7 | 234 | 3 | 1.50.10.50 | |
| Domain | Cadherin_CS | 6.90e-05 | 109 | 234 | 8 | IPR020894 | |
| Domain | CADHERIN_1 | 8.90e-05 | 113 | 234 | 8 | PS00232 | |
| Domain | Cadherin | 8.90e-05 | 113 | 234 | 8 | PF00028 | |
| Domain | Cadherin_tail | 9.30e-05 | 37 | 234 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 9.30e-05 | 37 | 234 | 5 | IPR031904 | |
| Domain | CADHERIN_2 | 9.47e-05 | 114 | 234 | 8 | PS50268 | |
| Domain | - | 9.47e-05 | 114 | 234 | 8 | 2.60.40.60 | |
| Domain | CA | 1.01e-04 | 115 | 234 | 8 | SM00112 | |
| Domain | Carb-bd-like_fold | 1.04e-04 | 8 | 234 | 3 | IPR013784 | |
| Domain | Glyco_hydro_47 | 1.04e-04 | 8 | 234 | 3 | IPR001382 | |
| Domain | Cadherin-like | 1.07e-04 | 116 | 234 | 8 | IPR015919 | |
| Domain | Cadherin | 1.21e-04 | 118 | 234 | 8 | IPR002126 | |
| Domain | Cadherin_2 | 1.62e-04 | 65 | 234 | 6 | PF08266 | |
| Domain | Cadherin_N | 1.62e-04 | 65 | 234 | 6 | IPR013164 | |
| Domain | - | PECAM1 INSRR CEACAM4 MET NOMO2 PTPRZ1 CNTN5 ADGRF5 FGFR4 USH2A ADGRA3 NPHS1 PLXNA3 NDNF COL12A1 COL20A1 ROR1 VWA1 NOMO1 NOMO3 | 2.71e-04 | 663 | 234 | 20 | 2.60.40.10 |
| Domain | TraB | 4.65e-04 | 3 | 234 | 2 | PF01963 | |
| Domain | Pheromone_shutdown_TraB | 4.65e-04 | 3 | 234 | 2 | IPR002816 | |
| Domain | NCD3G | 5.06e-04 | 13 | 234 | 3 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 5.06e-04 | 13 | 234 | 3 | IPR011500 | |
| Domain | FN3 | 5.56e-04 | 185 | 234 | 9 | SM00060 | |
| Domain | Ig-like_fold | PECAM1 INSRR CEACAM4 MET NOMO2 PTPRZ1 CNTN5 ADGRF5 FGFR4 USH2A ADGRA3 NPHS1 PLXNA3 NDNF COL12A1 COL20A1 ROR1 VWA1 NOMO1 NOMO3 | 6.01e-04 | 706 | 234 | 20 | IPR013783 |
| Domain | Dynein_heavy_chain_D4_dom | 6.38e-04 | 14 | 234 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.38e-04 | 14 | 234 | 3 | IPR024743 | |
| Domain | MT | 6.38e-04 | 14 | 234 | 3 | PF12777 | |
| Domain | AAA_8 | 6.38e-04 | 14 | 234 | 3 | PF12780 | |
| Domain | GPCR_3_CS | 6.38e-04 | 14 | 234 | 3 | IPR017979 | |
| Domain | Laminin_G | 7.89e-04 | 58 | 234 | 5 | IPR001791 | |
| Domain | DHC_fam | 7.90e-04 | 15 | 234 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 7.90e-04 | 15 | 234 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.90e-04 | 15 | 234 | 3 | IPR004273 | |
| Domain | RAS | 9.27e-04 | 35 | 234 | 4 | PS51421 | |
| Domain | FN3 | 9.36e-04 | 199 | 234 | 9 | PS50853 | |
| Domain | fn3 | 1.02e-03 | 162 | 234 | 8 | PF00041 | |
| Domain | Small_GTPase_Ras | 1.15e-03 | 37 | 234 | 4 | IPR020849 | |
| Domain | FN3_dom | 1.32e-03 | 209 | 234 | 9 | IPR003961 | |
| Domain | Lig_chan-Glu_bd | 1.38e-03 | 18 | 234 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 1.38e-03 | 18 | 234 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.38e-03 | 18 | 234 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 1.38e-03 | 18 | 234 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 1.38e-03 | 18 | 234 | 3 | IPR001508 | |
| Domain | Lig_chan | 1.38e-03 | 18 | 234 | 3 | PF00060 | |
| Domain | PBPe | 1.38e-03 | 18 | 234 | 3 | SM00079 | |
| Domain | PROTEIN_KINASE_TYR | 1.39e-03 | 97 | 234 | 6 | PS00109 | |
| Domain | Gal_Lectin | 1.52e-03 | 5 | 234 | 2 | PF02140 | |
| Domain | Lectin_gal-bd_dom | 1.52e-03 | 5 | 234 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 1.52e-03 | 5 | 234 | 2 | PS50228 | |
| Domain | Cadherin_C | 1.85e-03 | 42 | 234 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.85e-03 | 42 | 234 | 4 | PF16492 | |
| Domain | RasGEFN | 1.89e-03 | 20 | 234 | 3 | SM00229 | |
| Domain | - | 1.89e-03 | 20 | 234 | 3 | 3.30.565.10 | |
| Domain | GPCR_Rhodpsn_7TM | OR5D16 NTSR2 OR13G1 PTAFR NPFFR2 OR5J2 AGTR2 TAAR9 CYSLTR2 MCHR1 GPR37 FPR1 OR4M1 TAAR5 OR10Z1 OR4M2 GPR176 GPR45 | 2.02e-03 | 670 | 234 | 18 | IPR017452 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GABRE NTSR2 PTAFR NPFFR2 AGTR2 TAAR9 CYSLTR2 MCHR1 FPR1 GRIA4 TAAR5 GRIK2 GRIK3 GRM2 GRM3 | 2.29e-06 | 272 | 181 | 15 | M13380 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PDE2A NTSR2 PTAFR ADCY5 NPFFR2 AGTR2 C3 TAAR9 GNAT1 TAS2R30 TAS2R50 CYSLTR2 MCHR1 GPR37 FPR1 GRK6 CASR TAAR5 GRM2 GRM3 GPR176 GPR45 | 2.83e-05 | 646 | 181 | 22 | MM14962 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PDE2A NTSR2 PTAFR ADCY5 NPFFR2 AGTR2 C3 TAAR9 GNAT1 TAS2R30 TAS2R50 CYSLTR2 MCHR1 GPR37 FPR1 GRK6 CASR TAAR5 GRM2 GRM3 PPP3CA GPR176 GPR45 | 3.37e-05 | 702 | 181 | 23 | M746 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.03e-04 | 37 | 181 | 5 | MM15067 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.33e-04 | 39 | 181 | 5 | M793 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | NTSR2 PTAFR NPFFR2 AGTR2 C3 TAAR9 TAS2R30 TAS2R50 CYSLTR2 MCHR1 GPR37 FPR1 CASR TAAR5 GRM2 GRM3 | 1.36e-04 | 430 | 181 | 16 | MM15160 |
| Pathway | WP_GPCRS_ODORANT | OR5J2 TAAR9 ADGRF5 TAS2R30 TAS2R50 ADGRA3 GPR37 TAAR5 GPR176 | 1.93e-04 | 157 | 181 | 9 | MM15872 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | ADCY5 AGTR2 C3 GNAT1 TAS2R30 TAS2R50 MCHR1 GPR37 FPR1 CASR GRM2 GRM3 PPP3CA | 2.10e-04 | 314 | 181 | 13 | M600 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ENDOD1 ITGA6 MRPS22 MYORG XYLT2 MET LMF2 TM9SF2 NOMO2 TMEM259 SGCE FGFR4 ADGRA3 NPC1 LARGE2 PLXNA3 FAT4 COL12A1 LAMC1 GRIK2 NOMO1 PDIA4 IGF2R TENM3 LRP10 GUSB SLC7A5 ATP1A1 EDEM1 DSEL GALNT4 MAN1B1 | 1.12e-10 | 1201 | 244 | 32 | 35696571 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | ACACB ESR1 INSRR FAM186A FGFR4 HSPA8 TPTE2 ROR1 MUC16 APOB ARMCX5 DNAH7 PPP3CA RASGEF1B ATP1A1 EDEM1 PTPN20 | 9.01e-09 | 420 | 244 | 17 | 28065597 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ENDOD1 ITGA6 RB1CC1 JAK2 MET FAF2 TM9SF2 SGCE HSPA8 ADGRA3 GNPAT CERS2 TMPPE GPR37 ROR1 GALNT12 PCDHA4 APOB DIS3 EVA1C USP8 IGF2R LRP10 GUSB AGMAT SEPTIN7 MAN1B1 | 9.41e-09 | 1061 | 244 | 27 | 33845483 |
| Pubmed | RAPGEF6 ACACB ITGA6 MET STXBP1 OSBPL10 DMD ADGRL2 PLEKHA6 NOMO1 USP8 IGF2R TENM3 GUSB SLC7A5 ATP1A1 | 5.93e-08 | 421 | 244 | 16 | 36976175 | |
| Pubmed | 3.41e-07 | 3 | 244 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 3.41e-07 | 3 | 244 | 3 | 25576386 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 6.22e-07 | 24 | 244 | 5 | 35746896 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 7.67e-07 | 72 | 244 | 7 | 10380929 | |
| Pubmed | 1.12e-06 | 12 | 244 | 4 | 11891216 | ||
| Pubmed | 1.22e-06 | 77 | 244 | 7 | 10835267 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.36e-06 | 4 | 244 | 3 | 31833031 | |
| Pubmed | 1.36e-06 | 4 | 244 | 3 | 15254225 | ||
| Pubmed | 1.36e-06 | 4 | 244 | 3 | 9267806 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.58e-06 | 80 | 244 | 7 | 10716726 | |
| Pubmed | 1.72e-06 | 81 | 244 | 7 | 22723691 | ||
| Pubmed | ENDOD1 PSMC3 RB1CC1 MET LMF2 TM9SF2 NOMO2 TMEM259 C3 HSPA4 HSPA8 NPC1 CERS2 MARS2 COL12A1 USP24 LAMC1 APOB PDIA4 PPP3CA IGF2R GUSB MRPS34 HARS1 ATP1A1 SEPTIN7 | 1.74e-06 | 1297 | 244 | 26 | 33545068 | |
| Pubmed | ACACB COLGALT2 CSMD2 STXBP1 FAF2 GSE1 WDR17 FAT4 USP24 MUC16 LAMC1 XPC DNAH7 USP8 SLC22A16 NOMO3 DNAH11 | 3.19e-06 | 638 | 244 | 17 | 31182584 | |
| Pubmed | 3.38e-06 | 5 | 244 | 3 | 9466455 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ENDOD1 PSMB2 PSMC3 LMF2 FAF2 TM9SF2 TMEM259 HEATR5B ADGRL2 HSPA4 NPC1 USP24 POR HAT1 GALNT12 PDIA4 IGF2R ATP1A1 SEPTIN7 NOMO3 MAN1B1 | 3.66e-06 | 942 | 244 | 21 | 31073040 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | NOMO2 C3 HSPA4 NAGK USP24 NOMO1 PDIA4 USP8 UTP25 ATP1A1 SEPTIN7 NOMO3 | 6.60e-06 | 344 | 244 | 12 | 30333137 |
| Pubmed | 6.72e-06 | 6 | 244 | 3 | 27056679 | ||
| Pubmed | 6.72e-06 | 6 | 244 | 3 | 9694898 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 8.53e-06 | 68 | 244 | 6 | 11230163 | |
| Pubmed | 1.17e-05 | 150 | 244 | 8 | 32423001 | ||
| Pubmed | 1.17e-05 | 7 | 244 | 3 | 12009310 | ||
| Pubmed | Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor. | 1.17e-05 | 7 | 244 | 3 | 15538384 | |
| Pubmed | 1.17e-05 | 7 | 244 | 3 | 17428973 | ||
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 1.17e-05 | 7 | 244 | 3 | 9016303 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 1.17e-05 | 7 | 244 | 3 | 9651535 | |
| Pubmed | 1.17e-05 | 7 | 244 | 3 | 1310861 | ||
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 1.39e-05 | 74 | 244 | 6 | 10817752 | |
| Pubmed | 1.54e-05 | 257 | 244 | 10 | 16335952 | ||
| Pubmed | 1.86e-05 | 8 | 244 | 3 | 19125103 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 1.86e-05 | 8 | 244 | 3 | 8163463 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.86e-05 | 8 | 244 | 3 | 15257293 | |
| Pubmed | 1.86e-05 | 8 | 244 | 3 | 10757814 | ||
| Pubmed | 2.23e-05 | 164 | 244 | 8 | 32409323 | ||
| Pubmed | 2.25e-05 | 24 | 244 | 4 | 17452356 | ||
| Pubmed | 2.42e-05 | 49 | 244 | 5 | 21362503 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.78e-05 | 9 | 244 | 3 | 36261522 | |
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 2.78e-05 | 9 | 244 | 3 | 9051806 | |
| Pubmed | ACACB MEN1 STXBP1 ZBED4 SACS FAM186A DMD HSPA8 PLXNA3 COL20A1 PCDHGA6 PCDHGA5 PCDHGA2 GRK6 MYO18A GRIA4 APOB XPC PDIA4 USP8 SNX25 OGDHL SLC7A5 ATP1A1 ZNF292 | 3.25e-05 | 1442 | 244 | 25 | 35575683 | |
| Pubmed | PSMC3 COLGALT2 MYORG MET LMF2 FAF2 NOMO2 HSPA8 NPC1 LAMC1 NOMO1 IGF2R GUSB ATP1A1 NOMO3 | 3.27e-05 | 613 | 244 | 15 | 22268729 | |
| Pubmed | Sex-hormone-driven innate antibodies protect females and infants against EPEC infection. | 3.95e-05 | 10 | 244 | 3 | 30250184 | |
| Pubmed | ACACB MET FAF2 OSBPL10 ADGRL2 PCDH10 FAT4 POR MUC16 APOB DNAH7 PPP3CA IGF2R TENM3 SLC7A5 ATP1A1 COIL | 4.00e-05 | 777 | 244 | 17 | 35844135 | |
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 4.26e-05 | 55 | 244 | 5 | 38945485 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | TRABD2B RC3H1 PSMB2 OR13G1 EXTL1 CSMD2 SMYD2 NKAIN1 HSD3B2 ADGRL2 USH2A GNPAT TDRD5 MAN1C1 ROR1 PPCS OR10Z1 UTP25 AGMAT ATP1A1 | 4.55e-05 | 1031 | 244 | 20 | 16710414 |
| Pubmed | 4.64e-05 | 235 | 244 | 9 | 32614325 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 23616537 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 24594358 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 34561764 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 25201024 | ||
| Pubmed | Evidence for multiple, developmentally regulated isoforms of Ptprq on hair cells of the inner ear. | 4.90e-05 | 2 | 244 | 2 | 20715155 | |
| Pubmed | Polyglutamylation is a post-translational modification with a broad range of substrates. | 4.90e-05 | 2 | 244 | 2 | 18045879 | |
| Pubmed | Fatty acid transport protein 2 interacts with ceramide synthase 2 to promote ceramide synthesis. | 4.90e-05 | 2 | 244 | 2 | 35181339 | |
| Pubmed | Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2. | 4.90e-05 | 2 | 244 | 2 | 27903862 | |
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 17670976 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 15611275 | ||
| Pubmed | Loss of Adenylyl Cyclase Type-5 in the Dorsal Striatum Produces Autistic-Like Behaviors. | 4.90e-05 | 2 | 244 | 2 | 27878759 | |
| Pubmed | Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. | 4.90e-05 | 2 | 244 | 2 | 18199592 | |
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 28285415 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 33982216 | ||
| Pubmed | Atypical functional properties of GluK3-containing kainate receptors. | 4.90e-05 | 2 | 244 | 2 | 20007474 | |
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 22089319 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 21602804 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 21881873 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 8583212 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 32573735 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 15094479 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 21832989 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 25158312 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 28234895 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 15246118 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 18853337 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 24768041 | ||
| Pubmed | Hippocampal mossy fiber long-term depression in Grm2/3 double knockout mice. | 4.90e-05 | 2 | 244 | 2 | 21360593 | |
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 19638469 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 21628565 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 25691062 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 24053122 | ||
| Pubmed | Regulation of programmed cell death by basement membranes in embryonic development. | 4.90e-05 | 2 | 244 | 2 | 10974008 | |
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 17240362 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 38969501 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 25583490 | ||
| Pubmed | Metazoan Hsp70 machines use Hsp110 to power protein disaggregation. | 4.90e-05 | 2 | 244 | 2 | 22990239 | |
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 23624743 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 21785467 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 25950516 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 19386277 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 7965099 | ||
| Pubmed | HSD3B2, HSD17B1, HSD17B2, ESR1, ESR2 and AR expression in infertile women with endometriosis. | 4.90e-05 | 2 | 244 | 2 | 29664547 | |
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 24080311 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 25935522 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 16412386 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 35786929 | ||
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 28504721 | ||
| Pubmed | Estrogen receptor and laminin genetic polymorphism among women with pelvic organ prolapse. | 4.90e-05 | 2 | 244 | 2 | 29241914 | |
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 27911756 | ||
| Pubmed | USP8/UBPy-regulated sorting and the development of sperm acrosome: the recruitment of MET. | 4.90e-05 | 2 | 244 | 2 | 25744385 | |
| Pubmed | 4.90e-05 | 2 | 244 | 2 | 23392308 | ||
| Interaction | RYK interactions | MET SGCE FGFR4 PCDH10 ADGRA3 FAT4 PCDHGA6 PCDHGA5 ROR1 PDIA4 USP8 PPP3CA NOMO3 | 8.92e-07 | 212 | 227 | 13 | int:RYK |
| Interaction | CEACAM8 interactions | GLB1L ITGA6 LMF2 LARGE2 PLXNA3 FAT4 GALNT12 NOMO1 TENM3 GUSB | 9.83e-07 | 119 | 227 | 10 | int:CEACAM8 |
| Interaction | IDS interactions | ACACB XYLT2 FGFR4 TMPPE LARGE2 PLXNA3 GALNT12 NOMO1 PDIA4 GUSB | 1.06e-06 | 120 | 227 | 10 | int:IDS |
| Interaction | LYZL1 interactions | 7.69e-06 | 118 | 227 | 9 | int:LYZL1 | |
| Interaction | SCGB2A2 interactions | GLB1L XYLT2 NOMO2 FGFR4 SLC27A2 GNPAT LARGE2 PLXNA3 PTGES2 GALNT12 TENM3 GUSB | 9.04e-06 | 223 | 227 | 12 | int:SCGB2A2 |
| Interaction | IL5RA interactions | 1.15e-05 | 124 | 227 | 9 | int:IL5RA | |
| Interaction | BRICD5 interactions | ITGA6 MYORG MET TM9SF2 ADGRA3 TMEM234 PLXNA3 GALNT12 NOMO1 NOMO3 MAN1B1 | 1.32e-05 | 194 | 227 | 11 | int:BRICD5 |
| Interaction | B3GALT2 interactions | 1.44e-05 | 14 | 227 | 4 | int:B3GALT2 | |
| Interaction | NOCT interactions | 1.78e-05 | 49 | 227 | 6 | int:NOCT | |
| Interaction | FBXO2 interactions | ITGA6 MYORG MET LMF2 FGFR4 ADGRA3 NPC1 PLXNA3 COL12A1 LAMC1 NOMO1 IGF2R TENM3 LRP10 GUSB NOMO3 | 1.84e-05 | 411 | 227 | 16 | int:FBXO2 |
| Interaction | GPIHBP1 interactions | 2.02e-05 | 133 | 227 | 9 | int:GPIHBP1 | |
| Interaction | TMEM106B interactions | ENDOD1 MET LMF2 TM9SF2 NOMO2 TMEM259 C3 NPC1 CERS2 COL12A1 LAMC1 PDIA4 GUSB | 5.17e-05 | 309 | 227 | 13 | int:TMEM106B |
| Interaction | FBXO6 interactions | PSMC3 ITGA6 COLGALT2 MYORG MET LMF2 FAF2 NOMO2 FGFR4 HSPA8 NPC1 COL12A1 LAMC1 CDCP1 NOMO1 IGF2R LRP10 GUSB ATP1A1 EDEM1 NOMO3 | 6.53e-05 | 717 | 227 | 21 | int:FBXO6 |
| Interaction | EPHA2 interactions | PDE2A RAPGEF6 ACACB ITGA6 MET STXBP1 OSBPL10 FGFR4 DMD ADGRL2 HSPA4 TPTE2 ROR1 PLEKHA6 NOMO1 USP8 IGF2R TENM3 GUSB SLC7A5 ATP1A1 | 6.80e-05 | 719 | 227 | 21 | int:EPHA2 |
| Interaction | ERLIN2 interactions | RB1CC1 FAF2 TMEM259 FGFR4 HSPA4 HSPA8 NPC1 GRM2 PDIA4 EDEM1 RNF139 | 7.93e-05 | 236 | 227 | 11 | int:ERLIN2 |
| Interaction | SPSB4 interactions | 8.22e-05 | 124 | 227 | 8 | int:SPSB4 | |
| Interaction | DNAJA3 interactions | RC3H1 ESR1 MRPS22 MEN1 JAK2 MET FGFR4 HSPA8 GRK6 GRM2 NOMO1 PIKFYVE MRPS34 COIL | 8.36e-05 | 370 | 227 | 14 | int:DNAJA3 |
| Interaction | INSIG1 interactions | 9.72e-05 | 127 | 227 | 8 | int:INSIG1 | |
| Interaction | EDEM1 interactions | RB1CC1 XYLT2 FAF2 TMEM259 HSPA8 NPC1 PDIA4 EDEM1 RNF139 MAN1B1 | 1.02e-04 | 202 | 227 | 10 | int:EDEM1 |
| Interaction | GRIP1 interactions | 1.07e-04 | 96 | 227 | 7 | int:GRIP1 | |
| Interaction | NR3C1 interactions | ACACB COLGALT2 CSMD2 STXBP1 FAF2 GSE1 C3 WDR17 HSPA4 HSPA8 FAT4 USP24 POR MUC16 LAMC1 XPC DNAH7 USP2 USP8 SLC22A16 PDP1 ATP1A1 SRSF9 NOMO3 DNAH11 | 1.10e-04 | 974 | 227 | 25 | int:NR3C1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | RAPGEF6 HSPA4 SLC4A9 PCDHGA6 PCDHGA5 PCDHGA2 PCDHA13 PCDHA4 HARS1 | 3.49e-05 | 298 | 244 | 9 | chr5q31 |
| Cytoband | 5q31 | 3.68e-05 | 115 | 244 | 6 | 5q31 | |
| Cytoband | 8q11 | 4.16e-04 | 6 | 244 | 2 | 8q11 | |
| GeneFamily | Fibronectin type III domain containing | 2.86e-05 | 160 | 177 | 9 | 555 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.24e-05 | 40 | 177 | 5 | 321 | |
| GeneFamily | Clustered protocadherins | 4.06e-04 | 64 | 177 | 5 | 20 | |
| GeneFamily | Mannosidases alpha class 1 | 5.64e-04 | 4 | 177 | 2 | 1193 | |
| GeneFamily | Dyneins, axonemal | 5.67e-04 | 17 | 177 | 3 | 536 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 9.35e-04 | 5 | 177 | 2 | 1199 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 2.57e-03 | 8 | 177 | 2 | 281 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.28e-03 | 9 | 177 | 2 | 1234 | |
| GeneFamily | Trace amine receptors | 3.28e-03 | 9 | 177 | 2 | 188 | |
| GeneFamily | RAS type GTPase family | 3.39e-03 | 31 | 177 | 3 | 389 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | ENDOD1 MEN1 LMF2 FAF2 TM9SF2 TMEM259 TMEM97 ADGRL2 ADGRA3 CERS2 TMPPE NAGK POR PDIA4 LRP10 GUSB TTLL4 TMBIM4 SLC7A5 ATP1A1 | 5.27e-06 | 681 | 240 | 20 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | ENDOD1 MEN1 LMF2 FAF2 TM9SF2 TMEM259 TMEM97 ADGRL2 ADGRA3 CERS2 TMPPE NAGK POR PDIA4 LRP10 GUSB TTLL4 TMBIM4 SLC7A5 ATP1A1 | 8.40e-06 | 703 | 240 | 20 | MM1055 |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN | YJEFN3 SMYD2 OSBPL10 DMD PLXNA3 ZAN TRMT1 GRIK3 RASL11A TMBIM4 | 1.69e-05 | 200 | 240 | 10 | M7774 |
| CoexpressionAtlas | cerebral cortex | NOL4 PDE2A NTSR2 EXTL1 COLGALT2 LMTK3 CSMD2 YJEFN3 CA10 STAC2 STXBP1 PTPRZ1 CNTN5 NKAIN1 WDR17 PCDH10 DIRAS1 MCHR1 COL20A1 GPR37 RASGEF1A GRIA4 PCDHA4 GRIK2 GRIK3 GRM2 GRM3 FAM135B KCNH3 SLC6A7 SLC7A5 LRRC8B DIRAS2 GPR45 LGI1 | 2.62e-06 | 1428 | 224 | 35 | cerebral cortex |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NOL4 OTOGL PTPRQ DMD USH2A PCDH10 FAT4 COL12A1 ZAN APOB GRIK3 DNAH11 | 4.51e-10 | 184 | 243 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NOL4 OTOGL PTPRQ DMD USH2A PCDH10 FAT4 COL12A1 ZAN APOB GRIK3 DNAH11 | 4.51e-10 | 184 | 243 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NOL4 OTOGL PTPRQ DMD USH2A PCDH10 FAT4 COL12A1 ZAN APOB GRIK3 DNAH11 | 4.51e-10 | 184 | 243 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CA10 DNAH14 SMYD2 MET OTOGL CNTN5 ADGRF5 NKAIN1 COL12A1 GRM3 | 4.36e-08 | 174 | 243 | 10 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | TRABD2B MET C3 HSPA4 SLC27A2 ROR1 CASR PLEKHA6 OR10Z1 RASGEF1B | 4.86e-08 | 176 | 243 | 10 | 36f77d878a53b30465b0dea8333a3865dba75613 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CA10 DNAH14 SMYD2 OTOGL PTPRZ1 CNTN5 ADGRF5 COL12A1 GRM2 SLC6A7 | 5.70e-08 | 179 | 243 | 10 | 8766a5a066091879f521acfc612abf563ff78808 |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | EXTL1 GFRA2 ADGRL2 KCNH3 PPP3CA TENM3 PDP1 RASGEF1B ATP1A1 DIRAS2 | 8.17e-08 | 186 | 243 | 10 | 56c139e679d640ea901ead657a8e8887e0fca098 |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | ACACB SLC17A3 MET PEMT NOMO2 ROR1 NOMO1 RASGEF1B ATP1A1 NOMO3 | 1.05e-07 | 191 | 243 | 10 | ef16ad1c1cd2c0c0377957398c98775b62a81754 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-07 | 160 | 243 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-07 | 160 | 243 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.18e-07 | 170 | 243 | 9 | 5de2f7d16a05af74ebfb1ca42d0f9c3c3524692d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.08e-07 | 174 | 243 | 9 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-07 | 177 | 243 | 9 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-06 | 195 | 243 | 9 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-06 | 195 | 243 | 9 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.37e-06 | 196 | 243 | 9 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-06 | 196 | 243 | 9 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-06 | 197 | 243 | 9 | f98720cab066579fdac3ba24fb6fe4c5759dae4e | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-06 | 197 | 243 | 9 | f3ca63c7902d7530a29a85eb54f69b303031d150 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.43e-06 | 197 | 243 | 9 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.49e-06 | 198 | 243 | 9 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-06 | 199 | 243 | 9 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-06 | 200 | 243 | 9 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.03e-06 | 153 | 243 | 8 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.98e-06 | 161 | 243 | 8 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-06 | 115 | 243 | 7 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-06 | 115 | 243 | 7 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-06 | 115 | 243 | 7 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 164 | 243 | 8 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 164 | 243 | 8 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-06 | 169 | 243 | 8 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.07e-06 | 173 | 243 | 8 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | Epithelial-Epithelial-C_(AT2)|Epithelial / shred on cell class and cell subclass (v4) | 5.07e-06 | 173 | 243 | 8 | f57cbf5bd2a9e5db47b4919e9cd5e50781c1a990 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-06 | 174 | 243 | 8 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-06 | 174 | 243 | 8 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-06 | 180 | 243 | 8 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.06e-06 | 181 | 243 | 8 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-06 | 182 | 243 | 8 | e3248d108b51c49ca2c978636e13017e23b53860 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-06 | 184 | 243 | 8 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-06 | 186 | 243 | 8 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-06 | 186 | 243 | 8 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.62e-06 | 186 | 243 | 8 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.62e-06 | 186 | 243 | 8 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-06 | 187 | 243 | 8 | 81d7c3802667190f11e9dcd797ee7b88aadbb8de | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.96e-06 | 187 | 243 | 8 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-06 | 187 | 243 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 8.96e-06 | 187 | 243 | 8 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 9.32e-06 | 188 | 243 | 8 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 9.68e-06 | 189 | 243 | 8 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 190 | 243 | 8 | 8ff8c586237cf15f930416710bcff45205fe6f70 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 190 | 243 | 8 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 191 | 243 | 8 | 2f71f1fb6b5872d84860840b22e789a87ab14eec | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 191 | 243 | 8 | 4ab3056f9af2a6caed39f32288562f480811cd7b | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 191 | 243 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 191 | 243 | 8 | 5f8b3b2d38b37027901db9a1cccdbd1ff70f29de | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-05 | 191 | 243 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 193 | 243 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 193 | 243 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-05 | 194 | 243 | 8 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-05 | 195 | 243 | 8 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-05 | 195 | 243 | 8 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-05 | 196 | 243 | 8 | 8faac7fbdee3a9297023c3151ef1751605413e44 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 196 | 243 | 8 | e6adcfe1a00d4910e0b92848f8a80224e0d6db12 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-05 | 197 | 243 | 8 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-05 | 197 | 243 | 8 | 8b5d4e1c33a57c899c51feb9a6f347232f8910a3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 198 | 243 | 8 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.46e-05 | 200 | 243 | 8 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-05 | 200 | 243 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.46e-05 | 200 | 243 | 8 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.46e-05 | 200 | 243 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 149 | 243 | 7 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 149 | 243 | 7 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 150 | 243 | 7 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.05e-05 | 152 | 243 | 7 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 159 | 243 | 7 | c186bf05c61fac348cf41973827cced83fafd58a | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-05 | 162 | 243 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.08e-05 | 162 | 243 | 7 | 64353d33af0e82ebb7cf2bba74d52ca0586a58fc | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-05 | 163 | 243 | 7 | 9f5facfa1864eb63e2f8022ad7379d9252b7a254 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-05 | 164 | 243 | 7 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 165 | 243 | 7 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-05 | 167 | 243 | 7 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 168 | 243 | 7 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-05 | 168 | 243 | 7 | 948d9e9972bd2a4b503d55fa69b70dd568a35a67 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.88e-05 | 168 | 243 | 7 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 3.88e-05 | 168 | 243 | 7 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 168 | 243 | 7 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 169 | 243 | 7 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-05 | 169 | 243 | 7 | a4fd646b9bf87225131fca530bd6b52df9eaf489 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-05 | 169 | 243 | 7 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 4.03e-05 | 169 | 243 | 7 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-05 | 169 | 243 | 7 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-05 | 170 | 243 | 7 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-05 | 171 | 243 | 7 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-05 | 171 | 243 | 7 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.68e-05 | 173 | 243 | 7 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-05 | 173 | 243 | 7 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-05 | 174 | 243 | 7 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-05 | 174 | 243 | 7 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.85e-05 | 174 | 243 | 7 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.85e-05 | 174 | 243 | 7 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| Computational | B lymphoma expression clusters. | PDE2A RAPGEF6 CSMD2 OSBPL10 TMEM97 ROR1 USP2 DIRAS2 ZNF292 DNAH11 | 4.84e-05 | 149 | 152 | 10 | MODULE_361 |
| Computational | Genes in the cancer module 301. | PDE2A RAPGEF6 CSMD2 OSBPL10 TMEM97 ROR1 USP2 DIRAS2 ZNF292 DNAH11 | 7.94e-05 | 158 | 152 | 10 | MODULE_301 |
| Computational | Genes in the cancer module 238. | PDE2A RAPGEF6 CSMD2 OSBPL10 TMEM97 ROR1 USP2 DIRAS2 ZNF292 DNAH11 | 1.08e-04 | 164 | 152 | 10 | MODULE_238 |
| Drug | LY382884 | 1.29e-06 | 19 | 240 | 5 | CID000656723 | |
| Drug | L-BMAA | 2.68e-06 | 38 | 240 | 6 | CID000028558 | |
| Drug | Atpa | 5.58e-06 | 12 | 240 | 4 | CID000002252 | |
| Drug | AC1NSKBB | 7.99e-06 | 13 | 240 | 4 | CID005311256 | |
| Drug | AC1L1E5T | 1.31e-05 | 74 | 240 | 7 | CID000002653 | |
| Drug | LY293558 | 1.43e-05 | 30 | 240 | 5 | CID000127894 | |
| Drug | AC1L1EKQ | 1.75e-05 | 52 | 240 | 6 | CID000002834 | |
| Drug | decahydroisoquinoline | 1.98e-05 | 16 | 240 | 4 | CID000097812 | |
| Drug | willardine | 1.99e-05 | 32 | 240 | 5 | CID000005123 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 7.64e-06 | 17 | 228 | 4 | DOID:2921 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.80e-05 | 145 | 228 | 8 | DOID:1289 (implicated_via_orthology) | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.88e-05 | 71 | 228 | 6 | EFO_0007878, EFO_0007979 | |
| Disease | Sarcosine measurement | 2.74e-05 | 23 | 228 | 4 | EFO_0021668 | |
| Disease | asthma exacerbation measurement, response to corticosteroid | 4.64e-05 | 51 | 228 | 5 | EFO_0007614, GO_0031960 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.23e-04 | 13 | 228 | 3 | DOID:332 (biomarker_via_orthology) | |
| Disease | Addicted to cocaine | 1.77e-04 | 3 | 228 | 2 | C0858355 | |
| Disease | hyperparathyroidism (implicated_via_orthology) | 1.77e-04 | 3 | 228 | 2 | DOID:13543 (implicated_via_orthology) | |
| Disease | Schizophrenia | RAPGEF6 ESR1 RB1CC1 CSMD2 MET STXBP1 PEMT PTPRZ1 GNPAT MCHR1 GRK6 GRIA4 GRIK2 GRIK3 PLEKHA6 GRM2 GRM3 SEPTIN7 | 1.91e-04 | 883 | 228 | 18 | C0036341 |
| Disease | Malignant neoplasm of prostate | ESR1 JAK2 MET FAF2 HSD3B2 FGFR4 ALOX12B RAG1 NAGK LAMC1 PPP3CA IGF2R PDP1 ZNF292 | 3.40e-04 | 616 | 228 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | ESR1 JAK2 MET FAF2 HSD3B2 FGFR4 ALOX12B RAG1 NAGK LAMC1 PPP3CA IGF2R PDP1 ZNF292 | 3.40e-04 | 616 | 228 | 14 | C0033578 |
| Disease | age-related macular degeneration, cataract, glaucoma | 3.53e-04 | 4 | 228 | 2 | EFO_0001365, MONDO_0005041, MONDO_0005129 | |
| Disease | Familial Isolated Hyperparathyroidism | 3.53e-04 | 4 | 228 | 2 | C4551961 | |
| Disease | blood phosphate measurement | 4.27e-04 | 174 | 228 | 7 | EFO_0010972 | |
| Disease | serum metabolite measurement | SLC17A3 NPFFR2 GSE1 PEMT HSPA8 NBPF3 GRK6 APOB GRIK2 UGT1A1 PPP3CA IGF2R TENM3 SLC22A16 AGMAT SLC7A5 DIRAS2 SLC25A45 | 4.29e-04 | 945 | 228 | 18 | EFO_0005653 |
| Disease | fetal genotype effect measurement, body weights and measures | 5.60e-04 | 49 | 228 | 4 | EFO_0004324, EFO_0007959 | |
| Disease | hyperparathyroidism (is_implicated_in) | 5.85e-04 | 5 | 228 | 2 | DOID:13543 (is_implicated_in) | |
| Disease | activating signal cointegrator 1 complex subunit 1 measurement | 5.85e-04 | 5 | 228 | 2 | EFO_0801340 | |
| Disease | Dyslipidemias | 8.17e-04 | 24 | 228 | 3 | C0242339 | |
| Disease | Dyslipoproteinemias | 8.17e-04 | 24 | 228 | 3 | C0598784 | |
| Disease | response to antineoplastic agent, response to doxorubicin | 8.74e-04 | 6 | 228 | 2 | GO_0097327, GO_1902520 | |
| Disease | mental development measurement | 9.24e-04 | 25 | 228 | 3 | EFO_0008230 | |
| Disease | response to lithium ion | 9.31e-04 | 56 | 228 | 4 | GO_0010226 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.38e-03 | 274 | 228 | 8 | EFO_0004530, EFO_0004612 | |
| Disease | 1,5 anhydroglucitol measurement | 1.43e-03 | 29 | 228 | 3 | EFO_0008009 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.53e-03 | 64 | 228 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Neoplasm Metastasis | 1.56e-03 | 217 | 228 | 7 | C0027627 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 1.58e-03 | 30 | 228 | 3 | DOID:14330 (biomarker_via_orthology) | |
| Disease | intellectual disability (is_implicated_in) | 1.58e-03 | 30 | 228 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | response to dolutegravir | 1.58e-03 | 30 | 228 | 3 | EFO_0600017 | |
| Disease | argininate measurement | 1.61e-03 | 8 | 228 | 2 | EFO_0800055 | |
| Disease | Ventricular Dysfunction | 1.61e-03 | 8 | 228 | 2 | C0242973 | |
| Disease | anxiety | 1.82e-03 | 223 | 228 | 7 | EFO_0005230 | |
| Disease | Congenital adrenal hyperplasia | 2.06e-03 | 9 | 228 | 2 | C0001627 | |
| Disease | N6,N6-dimethyllysine measurement | 2.06e-03 | 9 | 228 | 2 | EFO_0800100 | |
| Disease | Hepatocellular carcinoma | 2.06e-03 | 9 | 228 | 2 | cv:C2239176 | |
| Disease | HEPATOCELLULAR CARCINOMA | 2.06e-03 | 9 | 228 | 2 | 114550 | |
| Disease | dihydroorotate measurement | 2.06e-03 | 9 | 228 | 2 | EFO_0800647 | |
| Disease | response to high fat food intake, triglyceride change measurement | 2.06e-03 | 9 | 228 | 2 | EFO_0007681, EFO_0007684 | |
| Disease | RNA-binding protein 24 measurement | 2.06e-03 | 9 | 228 | 2 | EFO_0802030 | |
| Disease | Adenocarcinoma | 2.11e-03 | 116 | 228 | 5 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 2.11e-03 | 116 | 228 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.11e-03 | 116 | 228 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.11e-03 | 116 | 228 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.11e-03 | 116 | 228 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.11e-03 | 116 | 228 | 5 | C0205641 | |
| Disease | retinal vasculature measurement | TTLL5 RB1CC1 GFRA2 SMYD2 LARGE2 LAMC1 USP2 UTP25 RASGEF1B LRRC8B METTL15 | 2.43e-03 | 517 | 228 | 11 | EFO_0010554 |
| Disease | bilirubin measurement | CNTN5 DMBT1 ADGRL2 FAT4 APOB OR10Z1 UGT1A1 SLC22A16 LRRC8B DNAH11 | 2.45e-03 | 442 | 228 | 10 | EFO_0004570 |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 2.57e-03 | 10 | 228 | 2 | EFO_0801535 | |
| Disease | OCIA domain-containing protein 1 measurement | 2.57e-03 | 10 | 228 | 2 | EFO_0008252 | |
| Disease | Combined oxidative phosphorylation deficiency | 2.91e-03 | 37 | 228 | 3 | cv:C4540031 | |
| Disease | cytochrome p450 3a4 measurement | 3.12e-03 | 11 | 228 | 2 | EFO_0020303 | |
| Disease | liver benign neoplasm (biomarker_via_orthology) | 3.12e-03 | 11 | 228 | 2 | DOID:916 (biomarker_via_orthology) | |
| Disease | chemotherapy-induced alopecia, response to antimicrotubule agent | 3.12e-03 | 11 | 228 | 2 | EFO_0005260, EFO_0005400 | |
| Disease | kynurenine measurement | 3.39e-03 | 39 | 228 | 3 | EFO_0008529 | |
| Disease | body height at birth | 3.64e-03 | 40 | 228 | 3 | EFO_0006784 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 3.73e-03 | 12 | 228 | 2 | EFO_0020833 | |
| Disease | polycystic ovary syndrome (is_marker_for) | 3.73e-03 | 12 | 228 | 2 | DOID:11612 (is_marker_for) | |
| Disease | Myeloproliferative disease | 3.73e-03 | 12 | 228 | 2 | C0027022 | |
| Disease | Mental Depression | 3.74e-03 | 254 | 228 | 7 | C0011570 | |
| Disease | age-related macular degeneration, disease progression measurement | 3.91e-03 | 41 | 228 | 3 | EFO_0001365, EFO_0008336 | |
| Disease | ovarian neoplasm | 3.93e-03 | 134 | 228 | 5 | C0919267 | |
| Disease | Calcinosis | 4.19e-03 | 42 | 228 | 3 | C0006663 | |
| Disease | Microcalcification | 4.19e-03 | 42 | 228 | 3 | C0521174 | |
| Disease | Tumoral calcinosis | 4.19e-03 | 42 | 228 | 3 | C0263628 | |
| Disease | aortic stenosis, aortic valve calcification | 4.19e-03 | 42 | 228 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | Malignant neoplasm of ovary | 4.32e-03 | 137 | 228 | 5 | C1140680 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 4.32e-03 | 137 | 228 | 5 | EFO_0007795, EFO_0010724 | |
| Disease | pleurisy (implicated_via_orthology) | 4.38e-03 | 13 | 228 | 2 | DOID:10247 (implicated_via_orthology) | |
| Disease | ejection fraction measurement | 4.47e-03 | 43 | 228 | 3 | EFO_0005527 | |
| Disease | Proteinuria | 4.47e-03 | 43 | 228 | 3 | C0033687 | |
| Disease | spleen volume | 4.47e-03 | 43 | 228 | 3 | EFO_0600047 | |
| Disease | Bladder Neoplasm | 4.73e-03 | 140 | 228 | 5 | C0005695 | |
| Disease | high grade glioma (implicated_via_orthology) | 4.77e-03 | 44 | 228 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of urinary bladder | 4.87e-03 | 141 | 228 | 5 | C0005684 | |
| Disease | Alcoholic Intoxication, Chronic | 5.00e-03 | 268 | 228 | 7 | C0001973 | |
| Disease | stomach cancer (is_marker_for) | 5.02e-03 | 142 | 228 | 5 | DOID:10534 (is_marker_for) | |
| Disease | eye disease | 5.09e-03 | 45 | 228 | 3 | EFO_0003966 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 5.09e-03 | 14 | 228 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | sickle cell anemia (is_marker_for) | 5.09e-03 | 14 | 228 | 2 | DOID:10923 (is_marker_for) | |
| Disease | Birth Weight | 5.09e-03 | 14 | 228 | 2 | C0005612 | |
| Disease | Adenocarcinoma of lung (disorder) | 5.47e-03 | 206 | 228 | 6 | C0152013 | |
| Disease | Neuroblastoma | 5.75e-03 | 47 | 228 | 3 | C0027819 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.97e-03 | 148 | 228 | 5 | C0279702 | |
| Disease | mean platelet volume | ENDOD1 PECAM1 ITGA6 JAK2 STAC2 GSE1 ZBED4 ADGRF5 ARGFX ZAN PCDHGA6 PCDHGA5 MAN1C1 PCDHGA2 TRMT1 CASR | 6.04e-03 | 1020 | 228 | 16 | EFO_0004584 |
| Disease | unipolar depression | NOL4 ESR1 TBC1D16 NPFFR2 CNTN5 DMD PZP RASGEF1A PCDHA4 GRIK2 GRIK3 CPM DNAH7 FAM135B SLC22A16 RASGEF1B METTL15 GPR45 | 6.09e-03 | 1206 | 228 | 18 | EFO_0003761 |
| Disease | myocardial infarction | 6.11e-03 | 350 | 228 | 8 | EFO_0000612 | |
| Disease | focal segmental glomerulosclerosis | 6.64e-03 | 16 | 228 | 2 | EFO_0004236 | |
| Disease | sickle cell anemia (is_implicated_in) | 6.64e-03 | 16 | 228 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | response to trauma exposure | 7.22e-03 | 51 | 228 | 3 | EFO_0008483 | |
| Disease | unipolar depression, sex interaction measurement | 7.22e-03 | 51 | 228 | 3 | EFO_0003761, EFO_0008343 | |
| Disease | unipolar depression, bipolar disorder | 7.42e-03 | 156 | 228 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Depressive disorder | 7.46e-03 | 289 | 228 | 7 | C0011581 | |
| Disease | Psychoses, Substance-Induced | 7.49e-03 | 17 | 228 | 2 | C0033941 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VADNDITPYLVSRFY | 841 | Q13523 | |
| FVEYIISPSQFYIRI | 476 | Q8NAT2 | |
| LLFSFSRDYSLDYLP | 481 | Q96Q91 | |
| LLEVVSFLLSPIYSY | 296 | P26439 | |
| FRLDYTQPLSDEYIT | 66 | Q6P093 | |
| SERISLTVAYGPDYV | 216 | A8MTB9 | |
| RTATPIYEELLYSDA | 216 | O75871 | |
| PDYNISLTVEYFLSE | 2391 | Q7Z408 | |
| NLLYPTTSYLEFETS | 1101 | Q68DQ2 | |
| SYLVASAIPSQDLYF | 481 | Q9H5V8 | |
| AVSLYYPLDLVFSFV | 1016 | Q8IWK6 | |
| ISSVETPYIDYTHLR | 401 | P41180 | |
| TIELASYPISDFASY | 316 | Q14416 | |
| FLPIFYVTSSDYRVQ | 776 | Q14416 | |
| LPIFYVTSSDYRVQT | 786 | Q14832 | |
| PSTVTEDYLRSFRPY | 211 | Q14687 | |
| TAPVYLAAVIEYLTA | 51 | P0C5Y9 | |
| TAPVYLAAVIEYLTA | 51 | P0C5Z0 | |
| PRFVSKLYYFEISEA | 3296 | Q6V0I7 | |
| AAPEARYTDIILYAS | 361 | P22455 | |
| SEEYLDLRLTFGPYS | 751 | P22455 | |
| LPTFYFRDVRTIEYL | 176 | P50052 | |
| ERLVASVPALYSDAY | 211 | A6NJG6 | |
| SVPALYSDAYDIFQI | 216 | A6NJG6 | |
| ITTDFIPSFRLVAYY | 521 | P01024 | |
| SLSEDYIVSRVPFNY | 2526 | Q96DT5 | |
| TPYRTDTLIEYASLE | 176 | O95490 | |
| LEISYVPSTYLTEIT | 1991 | P11532 | |
| FPEYFTYSVLLSLLA | 906 | O95622 | |
| IVRYFFELYVATPLA | 51 | Q96G23 | |
| DHYVITSYIPDFLTL | 426 | Q6P1M9 | |
| SDYRYSLIDGTFIIS | 146 | O94779 | |
| LRDRFPYLSESYLIT | 91 | Q9UJ70 | |
| YPAPSYTREEIFRES | 676 | Q5TC82 | |
| YPVDTIAKRFRYDSA | 551 | P15918 | |
| LRFADDPYTESYIST | 26 | Q92928 | |
| IYVPLSSNEADIYSF | 651 | P20742 | |
| YTTVLFANIYLAPLS | 321 | Q9Y5X5 | |
| VVLLDSTLPRSQYDY | 1111 | P69849 | |
| TGVLYALRSFDYEQL | 511 | Q9Y5H1 | |
| EALSFVSLIDGYYRL | 361 | O60674 | |
| YVFLSDIDFLPAYSL | 516 | Q8N3Y3 | |
| TGVLYALRSFDYEQL | 511 | Q9Y5G8 | |
| DAYLIVYSITDRASF | 151 | P55040 | |
| YPDSYLSQLLLFTVA | 191 | Q8NGK9 | |
| SIYIYARPFDSFSLD | 256 | A0A0X1KG70 | |
| PSLRSAYITSLYFAL | 446 | Q9ULD8 | |
| TYFPVADLSIIAALY | 76 | O00255 | |
| RIIDRLFSYTYSTAP | 301 | Q16654 | |
| YLYLTPQDYTRISSL | 1861 | O00763 | |
| DNYVLFTVSPTLYFL | 1516 | Q8TDY2 | |
| TEVSRAEVTYYDPTF | 6106 | Q8WXI7 | |
| ITELGPYTLDRDSLY | 13266 | Q8WXI7 | |
| STTEAEPYYRSLRDF | 1131 | O60500 | |
| IYINVLDIAPRYSSF | 336 | O00476 | |
| VVLLDSTLPRSQYDY | 1111 | Q5JPE7 | |
| YIRPASSYTFERDKV | 256 | Q8NGZ3 | |
| TGILYALRSFDYEQL | 511 | Q9Y5G7 | |
| LYAIRTQEYSIFAPL | 466 | Q7Z4F1 | |
| SPEEYVLAAISLYLD | 206 | Q9HC24 | |
| VLTFYRKEPFTLEAY | 431 | P34932 | |
| SYRTALTYYLDITNP | 366 | P16435 | |
| TILSFPAIALDRYYS | 131 | Q14439 | |
| LFYVSSAVTPLLYNA | 346 | O95665 | |
| DSAGYYLSDLERLVT | 146 | P11488 | |
| YLTVLSDSLYIPIFS | 476 | Q9C0I1 | |
| AFPYSLLIFVYDEVR | 991 | P05023 | |
| LAISPYYVSLAVSEE | 301 | Q8TDN1 | |
| SPSVSSEYYIRLEEH | 531 | Q96Q04 | |
| EYAYFDFPELLSLRT | 91 | Q5H9U9 | |
| ATLYSTRDRIPVYSA | 66 | O94919 | |
| FLYDTDRGYSILQAI | 156 | P48058 | |
| IPSDTLSLYPAFDIY | 211 | P51805 | |
| ILYSEYDPTRPFSEA | 326 | P03372 | |
| RPSSIPLAFDETYYS | 1341 | Q9NYQ8 | |
| RPSSQYIVALVFATY | 141 | Q8MH63 | |
| VVYETFHLSDLPSYT | 406 | Q9ULD0 | |
| SIYIYARPFDSFSLD | 256 | Q8NGD0 | |
| SIYIYARPFDSFSLD | 256 | Q8NGB6 | |
| GASEDTLLERLFSYY | 891 | Q92614 | |
| LSAVLPRVETVYTYL | 71 | O00408 | |
| TESYFIPEVRIYDSG | 91 | P16284 | |
| VVLLDSTLPRSQYDY | 1111 | Q15155 | |
| LLELTSSYSPDVSDY | 481 | P38432 | |
| RPSSQYIVALVFATY | 141 | Q01650 | |
| EISSYLFRDTPKRYF | 51 | Q8TB73 | |
| EAFRLLSPTERLYAY | 21 | Q9NY33 | |
| YYEVRLASVLGSEPS | 211 | Q9NY33 | |
| IFLGTTYDALSPELY | 241 | P03886 | |
| FPRVSYITALDFYIA | 331 | P78334 | |
| RPSSQYIVALVFATY | 141 | Q9GIP4 | |
| SDIVLYALDRDPTAY | 111 | P0C7V9 | |
| ATFPDTLTYSAYREL | 741 | P23229 | |
| TLTYSAYRELRAFPE | 746 | P23229 | |
| EYSLPVLTFVRKAAY | 1906 | P23471 | |
| LRDYEITPNSYFSLD | 156 | Q9P2E7 | |
| DRYVAIVSPLLYTVA | 121 | Q8NH18 | |
| TDDFITRLYYETPRF | 241 | Q6ZMK1 | |
| SDIVLYALDRDPTAY | 111 | A6NJ78 | |
| YLLTVPVFSEDALYL | 431 | Q0VAM2 | |
| SERLFYYIAVSLLPH | 156 | Q9P0J1 | |
| YTELPADRAYVVTLV | 186 | Q9Y5Y3 | |
| SFSVYLKRSYTPSEL | 486 | Q3SYG4 | |
| YDPLYSKRFSIFLSE | 376 | Q6P9F7 | |
| LRPETVESLFYLYRV | 596 | Q9UKM7 | |
| AIETELIYKYSPFRT | 166 | Q9Y6X9 | |
| RPYTTYLFEVSAVTT | 316 | Q9UMZ3 | |
| SFVYLRPKASYSLER | 256 | Q8NGY1 | |
| SALTYRLDPNDYFTL | 166 | Q9Y5I0 | |
| LTYIVALLYEEPFTA | 171 | Q9UBM1 | |
| RYFVSEYTPIDSNIA | 296 | O15118 | |
| EEYFYIATQGPLLST | 221 | Q4JDL3 | |
| TPASADSFIKYIRYA | 326 | Q4JDL3 | |
| DRFPYVALSKTYSVD | 91 | P10696 | |
| YLAAAVSDFYVPVSE | 176 | Q9HAB8 | |
| ALLTYRLSPNEYFSL | 166 | Q9UN74 | |
| LDRFYSTPFEYLELP | 421 | Q9H094 | |
| TFRDTYIPTIEDTYR | 31 | O95057 | |
| DEYALYRPLQSTEFS | 431 | Q9Y2I7 | |
| TVYSLLDTLSPAYRE | 106 | Q9P0R6 | |
| TSYPIYSSIEAAELA | 396 | P58658 | |
| SYYPLTGDTRLELEL | 991 | P04114 | |
| FYTPETIDTARLHYR | 1511 | Q9P2D3 | |
| LLETVHRYYTEFPTV | 256 | O14929 | |
| HRYYTEFPTVLDITA | 261 | O14929 | |
| DLPDTIYVLALTYDS | 426 | O15354 | |
| EVFDTYLVPISISYD | 271 | O15228 | |
| YSRSLTPDDDVFQYL | 211 | P14384 | |
| PLEYNSALYSRIFDD | 346 | P13671 | |
| PDTLYSVNLVALYSD | 1996 | Q99715 | |
| EFYEASPYEPVTSRL | 121 | O00451 | |
| LASRTEYLVSVFPIY | 436 | Q9P218 | |
| TFRESYIPTVEDTYR | 31 | Q96HU8 | |
| YRTLPTTSVIIAFYN | 131 | Q8N4A0 | |
| RSVLLYTTPTTYIDD | 216 | P08236 | |
| TRYSFYTFSLLDHLP | 181 | B0YJ81 | |
| LYFTLLQASEYFESP | 171 | P00414 | |
| IEYAPDFRFYITTKL | 3071 | Q8WXX0 | |
| RFLPITTSYDYDAPI | 321 | Q6UWU2 | |
| PSFESLIRAQVVYYS | 196 | Q9NQY0 | |
| AAIQFYEPYSRELLS | 271 | Q5VZ89 | |
| DYDNLPRTSVIIAFY | 131 | Q8IXK2 | |
| LYFSDVYTSLELPEE | 181 | Q9HBK9 | |
| LLSATIRSYVYFNTP | 1501 | Q0VDD8 | |
| RPELVESTYLLYQAT | 491 | Q92611 | |
| LSELTYDSLYLPNDF | 471 | O75342 | |
| ATQLSESYYILRPEV | 511 | Q9NR34 | |
| VEYSLEYGFLRLSQA | 211 | Q4ZIN3 | |
| ISRPTLTFVYLYNAA | 351 | Q99705 | |
| RSLVYTPDYDSFTLD | 576 | Q16798 | |
| ARDLLSFIVYYKESP | 511 | P14616 | |
| DIAVISDSYFPRYFI | 546 | P11047 | |
| LSYLSRSFRSLSYIP | 221 | Q3LI83 | |
| KPVLFFERSVYSDRY | 121 | P27707 | |
| FLYSDLTVLASDIPY | 1111 | Q49AJ0 | |
| VYQTPYTDERALLTL | 2026 | A6NE01 | |
| YVSLYPDFSSLSRAI | 146 | Q13002 | |
| TLDLYALDLEPYRYS | 261 | Q13003 | |
| YYESRDLKAFSAEPL | 541 | Q8IYK4 | |
| EYLSVAPFADYLDSI | 151 | P43250 | |
| ALYFSQTIPISEHYR | 46 | Q4AE62 | |
| NIEELYPETSSFITY | 221 | Q9NS85 | |
| DYYTRPVNLTEVTTL | 231 | Q9UJW0 | |
| PYSNDFTSLTYDLIR | 2306 | Q9UGM3 | |
| SYVYSAELFPTILRQ | 436 | Q9Y226 | |
| QDVIYITSAEYPRSL | 686 | Q9NZJ4 | |
| SDFLYIRVPTAYIDI | 876 | Q8IZU8 | |
| SLRYDLTVPFARYLA | 126 | P12081 | |
| SLITIFSAPNYLDVY | 301 | Q08209 | |
| ESSYFRTILPGILSY | 101 | Q9UKN5 | |
| LVSLESAERPNYFLY | 1271 | Q3ZCN5 | |
| SLYEGIDFYTSITRA | 286 | P11142 | |
| ILYAVVAYDLRPSLS | 286 | P00540 | |
| LYIIDAIFNSYPDSS | 31 | Q8WU17 | |
| RETSIFSYREDPIVY | 731 | P08581 | |
| QTLRYSDGDLTLIYF | 401 | P11717 | |
| YVFTDISYSIPHRER | 156 | P82650 | |
| SQLYAVDYETLTRPF | 31 | P82930 | |
| LVYSITDYDSYLSIR | 111 | Q6T310 | |
| LNPAFYSVEVRITAY | 71 | P59541 | |
| LNPAFYSVELRITSY | 71 | P59544 | |
| PSLSVTLADIYRELY | 431 | Q9Y6J9 | |
| VPAAYTSLFLYTDVV | 161 | O14804 | |
| TYSLLRDGFEIYTTE | 1086 | O75445 | |
| EELLPFSTYSYALQA | 4321 | O75445 | |
| VYTGLETRYRDFTLT | 4486 | O75445 | |
| IRLYAPFYSSDILIA | 436 | Q68CQ4 | |
| DVPLYYTLDQLSSTI | 441 | Q9NXH9 | |
| DPTYIEDFLLTYRTF | 436 | Q8TEU7 | |
| ETSYIRVYPERSTSY | 176 | Q13242 | |
| ISVDRYIAVTDPLTY | 126 | Q96RI9 | |
| PRYVVDRAAYSLTLF | 6 | Q7LBE3 | |
| VALFLISLVPYSYVE | 411 | Q9BU23 | |
| ETLKDRYYPSFIVSD | 381 | Q9H3E2 | |
| SEFRYTLFPIVYSII | 11 | P25105 | |
| IYLYTAELYPTIVRS | 461 | Q86VW1 | |
| RSEVTFSTPALYIYT | 211 | O14975 | |
| PAVSAGYLFLDIITY | 16 | P21462 | |
| LPFRFTYYTILDIFR | 101 | Q96CS3 | |
| AFLTLSILDRYYTPT | 136 | P49721 | |
| IYISFDIDALDPAYA | 271 | Q9BSE5 | |
| DYPYIEALSSALQIF | 141 | Q4KMZ8 | |
| RRPLVVVYYSVDFSF | 411 | P13667 | |
| YRTPTEALASFDYIV | 251 | Q9H7Z7 | |
| DTIYPVLDLLSYIRT | 1131 | Q8IZU2 | |
| VLYRYGSFSVTLDIV | 476 | P40967 | |
| AFLPYESQVYSLDSA | 136 | P61764 | |
| IYTHFTSPIRRYADV | 771 | Q9Y2L1 | |
| RFYPYSTIRTDAILS | 481 | Q92935 | |
| YKAISESYAFLPREA | 136 | O94818 | |
| EYVFTLPSAYARSIL | 586 | Q9BXB5 | |
| RDYYTDFLITLAVPS | 311 | O43556 | |
| TIVTAVTDEFPYYLR | 406 | Q99884 | |
| FYTTRRYLDGAESVL | 516 | Q8IZF2 | |
| LFISTLPFRADYYLR | 86 | Q9NS75 | |
| SLLYLRDALPEYSTF | 186 | P49406 | |
| ISDLGLSREIYSADY | 631 | Q01973 | |
| LTADSGYYVLELVPS | 236 | Q6PCB0 | |
| PVYYDELDAASSSLR | 431 | Q9Y2H5 | |
| PAYVAILLFYVSRAS | 6 | O95497 | |
| IQSYLLTAPIYSEEA | 436 | Q8N9B8 | |
| APSRTFYLYTVNILS | 416 | Q9BUI4 | |
| PVNAVTFLSYEYLLR | 271 | Q8N413 | |
| DILKLPYSTFRTYVF | 241 | Q13207 | |
| RVYFELDLTDPYTIS | 81 | A6NFA1 | |
| LINSLFLTDLYSPEY | 66 | Q16181 | |
| VDPVYETLRYGTSLA | 201 | Q6ZMT1 | |
| DSYLILETLPTEYDS | 156 | P17980 | |
| PFLLRYYSHESTSEE | 436 | Q8TBP0 | |
| VYSPYATLASEFLQR | 226 | P22309 | |
| LSEFLIEPTVDAYYA | 391 | O60281 | |
| RVFEYEPTIFYPTRS | 141 | A6XGL0 | |
| SSIVYFELDLTDPYT | 81 | Q86V40 | |
| LQFFYADLTYPTRIT | 2246 | Q9P273 | |
| TLHERLTLVSVYAPY | 136 | Q5BJF2 | |
| SRLSLLEDFGPRYYS | 16 | Q96GW9 | |
| LVISPVRTEDSATYY | 96 | A0JD37 | |
| ATSAYPYLLLYESRQ | 301 | Q9Y577 | |
| RLDSVESVLPYEYTA | 66 | Q99805 | |
| AERYVITIEDFYSVP | 931 | Q9UPU5 | |
| RYTRDGFDLDLTYVT | 211 | Q6XPS3 | |
| FTRVLPRDVDTYYLS | 241 | Q01831 | |
| VFTSYIDLLYPTEDR | 236 | Q9NRG4 | |
| VRTSDAYLLFYELAS | 586 | O75604 | |
| VTSYDPLRIYLFSDG | 771 | Q14679 | |
| LVRSEFYYEQAPSAS | 1921 | Q68DK2 | |
| AYILFYTSLGPRVTD | 1101 | P40818 | |
| YYLTLASTDLTLAVP | 71 | Q8WY98 | |
| RSFVEYVVYTDDPLV | 406 | Q9H1B5 | |
| KFDVRLYVLVTSYDP | 221 | Q6EMB2 | |
| EYRAYEDSSPSLLLS | 411 | Q9C030 | |
| YEDYSPGFEIRLTIL | 431 | Q7Z402 | |
| SRYHISELYDTLPSI | 2601 | Q9Y493 | |
| LVAEEPYLFSLAAYS | 106 | Q6ZT21 | |
| RYVFATLLDPRYKAS | 1001 | O75132 | |
| DLPYQSLSIDTFSYL | 231 | O95970 | |
| ELAYTLADGLEYSRT | 276 | P22033 | |
| EVSYLPRDFSTYRPL | 466 | Q6NSJ0 |